Market Size of Global Pet Diabetes Care Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 2.12 Billion |
Market Size (2029) | USD 2.88 Billion |
CAGR (2024 - 2029) | 6.22 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Pet Diabetes Care Market Analysis
The Global Pet Diabetes Care Market size is estimated at USD 2.12 billion in 2024, and is expected to reach USD 2.88 billion by 2029, growing at a CAGR of 6.22% during the forecast period (2024-2029).
COVID-19 had affected the pet diabetes market significantly. The COVID-19 pandemic imposed hurdles and concerns in the global pet animal health sector, including decreased marketing and sales efforts, reduced people visiting veterinary clinics, cancellation of regular pet check-ups, and fewer instances of insulin administration in veterinary facilities. As per the article published in 2021 under the title 'Diabetes among dogs increased by 10-20% during pandemic: Vets', cases of diabetes in dogs have increased 10-20% during COVID-19. Due to the increased lockdown and restrictions, there was a lack of routine checkups which lead to more cases of diabetes in dogs. Hence COVID-19 had a notable impact in the pet diabetic care market.
The major factors for the growth of the market include the rising prevalence of diabetes in pet animals, an increase in pet adoption, and the growing pet population. For instance, as per the American Pet Products Association's 2021-2022 National Pet Owners Survey, 69 million United States Household has a dog as a pet and 45.3 million households has a cat as a pet. The past few years have observed a significant rise in the adoption of animals, including dogs and cats as the favorite companions of human beings. Dogs and cats are not only the most preferred pets but are also known to improve the physical and mental health of humans. The developed countries have the leading position in companion animal ownership, owing to several factors, like favorable economic conditions, among others.
Furthermore, according to the American Pet Products Association's 2021-2022 National Pet Owners Survey, the basic annual expenses for Dogs and Cats for surgical vets are USD 458 and USD 201 respectively. Thus, the rise in adoption of pet animals is expected to increase the spending on health care needs of these animals which would in turn expected to boost the growth of the market over the forecast period.
Therefore, the market studied has a remarkable size, supported by the high population of pet animals, particularly cats and dogs. Hence, the increase in pet adoption has helped in driving the pet diabetes market over the forecast period. However, the high cost of diabetic medication and side effects relating to medicines and insulin restrain the market growth.
Pet Diabetes Care Industry Segmentation
As per the scope of the report, diabetes is a chronic disease that can also affect dogs and cats. Diabetes is more common in older pets, but it can also occur in younger or pregnant pets. Pet Diabetes Care market includes therapies that are used to treat or alleviate diabetes in animals or devices used to track or monitor blood glucose and administer insulin in animals. The Pet Diabetes Care Market is segmented by Drug Type (Insulin Therapy, Oral Medication), Device Type (Glucose Monitoring Devices, Insulin Delivery Devices), Animal Type (Canine, Feline), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Drug Type | |
Insulin Therapy | |
Oral Medication |
By Device Type | |
Glucose Monitoring Devices | |
Insulin Delivery Devices |
By Animal Type | |
Canine | |
Feline |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Pet Diabetes Care Market Size Summary
The pet diabetes care market is experiencing significant growth, driven by the increasing prevalence of diabetes among pet animals, a rise in pet adoption, and a growing pet population. The market has been impacted by the COVID-19 pandemic, which led to a decrease in routine veterinary visits and a rise in undiagnosed diabetes cases due to lockdowns. Despite these challenges, the market is poised for expansion, supported by the high ownership of companion animals, particularly dogs and cats, in developed countries. The demand for pet diabetes care is further bolstered by the rising healthcare expenditures for pets, as owners increasingly prioritize their pets' health and well-being.
In North America, the market is expected to witness robust growth due to rising pet adoption rates and increased spending on pet healthcare. The region's pet insurance market is also expanding, with a significant number of pets insured, particularly dogs. Key players in the market are focusing on strategic initiatives such as mergers, acquisitions, and research to enhance their market presence. Innovations in diabetes management, including the development of continuous glucose monitoring systems and novel insulin treatments, are expected to create new opportunities for market players. Despite the high cost of diabetic medications and potential side effects, the market is anticipated to grow, driven by advancements in research and development and the increasing incidence of diabetes in pets.
Global Pet Diabetes Care Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Diabetes and Obesity in Pet Animals
-
1.2.2 Increase in Pet Adoption
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Diabetes Medications
-
1.3.2 Adverse Reaction of Medications
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Drug Type
-
2.1.1 Insulin Therapy
-
2.1.2 Oral Medication
-
-
2.2 By Device Type
-
2.2.1 Glucose Monitoring Devices
-
2.2.2 Insulin Delivery Devices
-
-
2.3 By Animal Type
-
2.3.1 Canine
-
2.3.2 Feline
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Pet Diabetes Care Market Size FAQs
How big is the Global Pet Diabetes Care Market?
The Global Pet Diabetes Care Market size is expected to reach USD 2.12 billion in 2024 and grow at a CAGR of 6.22% to reach USD 2.88 billion by 2029.
What is the current Global Pet Diabetes Care Market size?
In 2024, the Global Pet Diabetes Care Market size is expected to reach USD 2.12 billion.